Liminatus Pharma, Inc. Soared
Wed, Feb 04, 2026 at 07:29 PM
Liminatus Pharma, Inc. (LIMN:NASDAQ) rocketted at $1.43, representing a gain of 33.6%. On Wed, Feb 04, 2026, LIMN:NASDAQ touched a New 2-Week High of $1.43. From Thu, Jan 22, 2026, the stock recorded 33.33% Up Days and 40.00% Green Days
The stock spiked on Wed, Feb 04, 2026 at $2.1 with a volume of 96M+.
About Liminatus Pharma, Inc. (LIMN:NASDAQ)
Liminatus Pharma, Inc. is pre-clinical stage biopharmaceutical company developing novel, immune-modulating cancer therapies.
Top 10 Gainers:
- Elong Power Holding Limited (ELPW:NASDAQ), 61.09%
- Boxlight Corporation (BOXL:NASDAQ), 56.59%
- Silicon Laboratories Inc. (SLAB:NASDAQ), 48.89%
- 8x8, Inc. (EGHT:NYSE), 46.99%
- SUNation Energy Inc. (SUNE:NASDAQ), 46.03%
- Jianzhi Education Technology Group Company Limited (JZ:NASDAQ), 40.63%
- Enphase Energy, Inc. (ENPH:NASDAQ), 38.6%
- Liminatus Pharma, Inc. (LIMN:NASDAQ), 33.64%
- Phaos Technology Holdings (Cayman) Limited Class A (POAS:NYSEMKT), 32.26%
- Virtuix Holdings Inc. (VTIX:NASDAQ), 30%